Cr2, a Candidate Gene in the Murine Sle1c Lupus Susceptibility Locus, Encodes a Dysfunctional Protein

This publication has 49 references indexed in Scilit:

• Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2
  The Journal of Experimental Medicine, 2000
• Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.
  Journal of Clinical Investigation, 1998
• Antibody response to a T-dependent antigen requires B cell expression of complement receptors.
  The Journal of Experimental Medicine, 1996
• Disruption of the Cr2 Locus Results in a Reduction in B-1a Cells and in an Impaired B Cell Response to T-Dependent Antigen
  Published by Elsevier ,1996
• Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)
  Clinical and Experimental Immunology, 1995
• Polygenic control of susceptibility to murine systemic lupus erythematosus
  Immunity, 1994
• Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells
  International Immunology, 1993
• Proliferation of resting B cells is modulated by CR2 and CR1
  Immunology Letters, 1989
• Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.
  The Journal of Experimental Medicine, 1988
• Complement Dependence of Localisation of Aggregated IgG in Germinal Centres
  Scandinavian Journal of Immunology, 1975